Showing results (511-520 of 977) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|February 19, 2022
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancerIlenia Migliaccio, Marta Paoli, Emanuela Risi, et al.
NPJ Breast Cancer|February 18, 2022
Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort studyMerav Fraenkel, Victor Novack, Yuval Mizrakli, et al.
NPJ Breast Cancer|October 28, 2021
Breast cancer dormancy is associated with a 4NG1 state and not senescenceChloé Prunier, Ania Alay, Michiel van Dijk, et al.
NPJ Breast Cancer|July 14, 2022
Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort studyZhengyi Deng, Miranda R Jones, Mei-Cheng Wang, et al.
NPJ Breast Cancer|December 14, 2023
Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancerM Chadha, J White, S M Swain, et al.
NPJ Breast Cancer|December 2, 2023
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targetsLukas Beumers, Efstathios-Iason Vlachavas, Simone Borgoni, et al.
NPJ Breast Cancer|December 2, 2023
Post-diagnosis weight trajectories and mortality among women with breast cancerLeah S Puklin, Fangyong Li, Brenda Cartmel, et al.
NPJ Breast Cancer|November 30, 2023
ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferationRosemary J Huggins, Geoffrey L Greene
NPJ Breast Cancer|November 30, 2023
Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patientsLinda Vidarsdottir, Elinborg J Olafsdottir, Rosa B Barkardottir, et al.
NPJ Breast Cancer|September 9, 2023
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trialSonja Vliek, Florentine S Hilbers, Erik van Werkhoven, et al.
Pageof 98